Innate Pharma SA (IPHA) stock
IPHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as IPHYF
$1.03−0.30 (-22.56%)
Close on Nov 18, 2026Market cap $96.53MP/E –Yield –
Innate Pharma gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Innate Pharma
Innate Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?